SEC Form 3 · accession 0001437749-16-040312
BioCardia, Inc. · BCDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay M Moyes
Director
Period of report
Oct 24, 2016
Accepted (ET)
Oct 26, 2016 · 2:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000925741
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 159,009 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director stock option (right to buy)F2 | $0.13 | holding | — | — | — | — | Nov 11, 2020 | Common Stock | 162,941 | — | D |
| Director stock option (right to buy)F2 | $0.13 | holding | — | — | — | — | Dec 23, 2020 | Common Stock | 54,307 | — | D |
Explanation of responses
- F1These shares are held by Drayton Investments LLC, for which the Reporting Person serves as a managing member.
- F2The shares subject to the option are fully vested and immediately exercisable.
Remarks
Exhibit 24 – Power of Attorney